Goldman Sachs’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-48,900
Closed -$1.31M – 7206
2016
Q1
$1.31M Sell
48,900
-7,600
-13% -$186K ﹤0.01% 3846
2015
Q4
$1.6M Sell
56,500
-8,500
-13% -$245K ﹤0.01% 3835
2015
Q3
$1.81M Buy
65,000
+15,000
+30% +$542K ﹤0.01% 3903
2015
Q2
$2.06M Hold
50,000
– – ﹤0.01% 3799
2015
Q1
$1.52M Buy
+50,000
New +$1.3M ﹤0.01% 4049

Other funds holding RGEN

Goldman Sachs's RGEN Position: Q2 2026 in Review

Goldman Sachs increased its Repligen (RGEN) stake by 48% in Q2 2026, buying an estimated $38.6M and bringing the position to 965,411 shares worth $132M. The position accounts for 0.01% of the portfolio, ranked #1023.

Goldman Sachs first reported a position in RGEN in Q4 2013 and has held it in 51 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Goldman Sachs held 965,411 shares of Repligen worth $132M as of Q2 2026.
  • Goldman Sachs bought 314,064 Repligen shares in Q2 2026, an estimated $38.6M.
  • Repligen made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1023 holding.
  • Goldman Sachs first reported a position in Repligen in Q4 2013 and has held it in 51 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.